RelapseTripleNegativeBreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BreastTomosynthesisExcisionalBiopsyBreastCancerGuaranteedRenewableInsuranceMorpheaEstrogenCachexiaMegestrolAcetateECOGScoreSelf-examinationNodeNegativeACChemotherapymTORInhibitorsNeoadjuvantTherapyMetastasisCDK4/6InhibitorsAxillarySamplingMultimodalityTherapyGermlineMutationPagetDiseaseBOCACytotoxicDefinitiveSurgeryMastectomyPrecisionMedicine1 in 8womenCytostaticPhyllodesTumorKappaEpsilonFamilyHistoryAdenocarcinomaPhysicalactivity mayreduce therisk of breastcancersBRCAGeneTyrosine-KinaseInhibitorPalbociclibAngiogenesisDoseDenseTherapyCMFChemotherapyGenomicTestingLumpAntiemeticCAMLymphNodeStatusBilateralProphylacticMastectomyGailModelDocetaxelNodePositiveAdjuvantTherapyMastodyniaAdvocacyTamoxifenGeneticPredispositionLapatinibGeneticCounselingAnastrozoleEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearLumpectomyFibroadenomaCheckpointInhibitorNeoplasmCalcificationsWomen ages40+ shouldhave a clinicalbreast examat least yearlyFISHLymphoscintigraphyBrachytherapyInvasiveBreastCancerER-RADAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerAbsoluteRiskChemotherapyPaclitaxelTumorGradeDimplingPARPInhibitorsPI3KinaseInhibitorsGeneMutationEGFR(epidermalgrowth factorreceptor)StagingCo-survivorEstradiol5-FluorouracilPalpationHerceptinChemopreventionDown-StagingIntraductalPapillomaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltAntibodyTherapyTriplePositiveBreastCancerHormoneReceptorStatusAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenBI-RADSOvarianSuppressionKi-67RateImmunotherapyLCISApoptosisOligometastasesCapecitabinePathologicResponseBevacizumabMethotrexateHER-2RadiotherapyCystSERMWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Breast cancer isthe leading causeof death in womenbetween the agesof 40 and 55HormoneReplacementTherapyER+ProgestinAlopeciaFlowCytometryCyclophosphamideAromataseInhibitorsAyurvedaMRIBiopsyIn-situCarcinomaDoxorubicinMultifocalTumorsRaloxifeneRelapseTripleNegativeBreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BreastTomosynthesisExcisionalBiopsyBreastCancerGuaranteedRenewableInsuranceMorpheaEstrogenCachexiaMegestrolAcetateECOGScoreSelf-examinationNodeNegativeACChemotherapymTORInhibitorsNeoadjuvantTherapyMetastasisCDK4/6InhibitorsAxillarySamplingMultimodalityTherapyGermlineMutationPagetDiseaseBOCACytotoxicDefinitiveSurgeryMastectomyPrecisionMedicine1 in 8womenCytostaticPhyllodesTumorKappaEpsilonFamilyHistoryAdenocarcinomaPhysicalactivity mayreduce therisk of breastcancersBRCAGeneTyrosine-KinaseInhibitorPalbociclibAngiogenesisDoseDenseTherapyCMFChemotherapyGenomicTestingLumpAntiemeticCAMLymphNodeStatusBilateralProphylacticMastectomyGailModelDocetaxelNodePositiveAdjuvantTherapyMastodyniaAdvocacyTamoxifenGeneticPredispositionLapatinibGeneticCounselingAnastrozoleEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearLumpectomyFibroadenomaCheckpointInhibitorNeoplasmCalcificationsWomen ages40+ shouldhave a clinicalbreast examat least yearlyFISHLymphoscintigraphyBrachytherapyInvasiveBreastCancerER-RADAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerAbsoluteRiskChemotherapyPaclitaxelTumorGradeDimplingPARPInhibitorsPI3KinaseInhibitorsGeneMutationEGFR(epidermalgrowth factorreceptor)StagingCo-survivorEstradiol5-FluorouracilPalpationHerceptinChemopreventionDown-StagingIntraductalPapillomaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltAntibodyTherapyTriplePositiveBreastCancerHormoneReceptorStatusAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenBI-RADSOvarianSuppressionKi-67RateImmunotherapyLCISApoptosisOligometastasesCapecitabinePathologicResponseBevacizumabMethotrexateHER-2RadiotherapyCystSERMWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Breast cancer isthe leading causeof death in womenbetween the agesof 40 and 55HormoneReplacementTherapyER+ProgestinAlopeciaFlowCytometryCyclophosphamideAromataseInhibitorsAyurvedaMRIBiopsyIn-situCarcinomaDoxorubicinMultifocalTumorsRaloxifene

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Relapse
  2. Triple Negative Breast Cancer
  3. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  4. Breast Tomosynthesis
  5. Excisional Biopsy
  6. Breast Cancer
  7. Guaranteed Renewable Insurance
  8. Morphea
  9. Estrogen
  10. Cachexia
  11. Megestrol Acetate
  12. ECOG Score
  13. Self-examination
  14. Node Negative
  15. AC Chemotherapy
  16. mTOR Inhibitors
  17. Neoadjuvant Therapy
  18. Metastasis
  19. CDK4/6 Inhibitors
  20. Axillary Sampling
  21. Multimodality Therapy
  22. Germline Mutation
  23. Paget Disease
  24. BOCA
  25. Cytotoxic
  26. Definitive Surgery
  27. Mastectomy
  28. Precision Medicine
  29. 1 in 8 women
  30. Cytostatic
  31. Phyllodes Tumor
  32. Kappa Epsilon
  33. Family History
  34. Adenocarcinoma
  35. Physical activity may reduce the risk of breast cancers
  36. BRCA Gene
  37. Tyrosine-Kinase Inhibitor
  38. Palbociclib
  39. Angiogenesis
  40. Dose Dense Therapy
  41. CMF Chemotherapy
  42. Genomic Testing
  43. Lump
  44. Antiemetic
  45. CAM
  46. Lymph Node Status
  47. Bilateral Prophylactic Mastectomy
  48. Gail Model
  49. Docetaxel
  50. Node Positive
  51. Adjuvant Therapy
  52. Mastodynia
  53. Advocacy
  54. Tamoxifen
  55. Genetic Predisposition
  56. Lapatinib
  57. Genetic Counseling
  58. Anastrozole
  59. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  60. Lumpectomy
  61. Fibroadenoma
  62. Checkpoint Inhibitor
  63. Neoplasm
  64. Calcifications
  65. Women ages 40+ should have a clinical breast exam at least yearly
  66. FISH
  67. Lymphoscintigraphy
  68. Brachytherapy
  69. Invasive Breast Cancer
  70. ER-
  71. RAD
  72. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  73. Absolute Risk
  74. Chemotherapy
  75. Paclitaxel
  76. Tumor Grade
  77. Dimpling
  78. PARP Inhibitors
  79. PI3 Kinase Inhibitors
  80. Gene Mutation
  81. EGFR (epidermal growth factor receptor)
  82. Staging
  83. Co-survivor
  84. Estradiol
  85. 5-Fluorouracil
  86. Palpation
  87. Herceptin
  88. Chemoprevention
  89. Down-Staging
  90. Intraductal Papilloma
  91. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  92. Antibody Therapy
  93. Triple Positive Breast Cancer
  94. Hormone Receptor Status
  95. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  96. BI-RADS
  97. Ovarian Suppression
  98. Ki-67 Rate
  99. Immunotherapy
  100. LCIS
  101. Apoptosis
  102. Oligometastases
  103. Capecitabine
  104. Pathologic Response
  105. Bevacizumab
  106. Methotrexate
  107. HER-2
  108. Radiotherapy
  109. Cyst
  110. SERM
  111. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  112. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  113. Hormone Replacement Therapy
  114. ER+
  115. Progestin
  116. Alopecia
  117. Flow Cytometry
  118. Cyclophosphamide
  119. Aromatase Inhibitors
  120. Ayurveda
  121. MRI
  122. Biopsy
  123. In-situ Carcinoma
  124. Doxorubicin
  125. Multifocal Tumors
  126. Raloxifene